Journal article 951 views
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION
Journal of the American College of Cardiology, Volume: 71, Issue: 11, Start page: A74
Swansea University Authors: Daniel Harris, Arron Lacey , Ashley Akbari , Michael Gravenor , Julian Halcox
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/s0735-1097(18)30615-6
Abstract
Poster Contribution - ACC.18
Published in: | Journal of the American College of Cardiology |
---|---|
ISSN: | 0735-1097 |
Published: |
Elsevier BV
2018
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa54252 |
first_indexed |
2020-10-19T10:05:55Z |
---|---|
last_indexed |
2020-10-30T04:08:23Z |
id |
cronfa54252 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2020-10-29T14:15:53.2857228</datestamp><bib-version>v2</bib-version><id>54252</id><entry>2018-03-01</entry><title>EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION</title><swanseaauthors><author><sid>e60c9c73b645f0e8033ae26fa8e634b8</sid><firstname>Daniel</firstname><surname>Harris</surname><name>Daniel Harris</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>b69d245574e754d2637cc9e76379fe11</sid><ORCID>0000-0001-7983-8073</ORCID><firstname>Arron</firstname><surname>Lacey</surname><name>Arron Lacey</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>70a544476ce62ba78502ce463c2500d6</sid><ORCID>0000-0003-0710-0947</ORCID><firstname>Michael</firstname><surname>Gravenor</surname><name>Michael Gravenor</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3676f695eeda169d0f8c618adf27c04b</sid><ORCID>0000-0001-6926-2947</ORCID><firstname>Julian</firstname><surname>Halcox</surname><name>Julian Halcox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-03-01</date><deptcode>MEDS</deptcode><abstract>Poster Contribution - ACC.18</abstract><type>Journal Article</type><journal>Journal of the American College of Cardiology</journal><volume>71</volume><journalNumber>11</journalNumber><paginationStart>A74</paginationStart><paginationEnd/><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0735-1097</issnPrint><issnElectronic/><keywords/><publishedDay>1</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-03-01</publishedDate><doi>10.1016/s0735-1097(18)30615-6</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-29T14:15:53.2857228</lastEdited><Created>2018-03-01T00:00:00.0000000</Created><path><level id="1">Professional Services</level><level id="2">ISS - Uncategorised</level></path><authors><author><firstname>Daniel</firstname><surname>Harris</surname><order>1</order></author><author><firstname>Arron</firstname><surname>Lacey</surname><orcid>0000-0001-7983-8073</orcid><order>2</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>3</order></author><author><firstname>Michael</firstname><surname>Gravenor</surname><orcid>0000-0003-0710-0947</orcid><order>4</order></author><author><firstname>Julian</firstname><surname>Halcox</surname><orcid>0000-0001-6926-2947</orcid><order>5</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2020-10-29T14:15:53.2857228 v2 54252 2018-03-01 EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION e60c9c73b645f0e8033ae26fa8e634b8 Daniel Harris Daniel Harris true false b69d245574e754d2637cc9e76379fe11 0000-0001-7983-8073 Arron Lacey Arron Lacey true false aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 70a544476ce62ba78502ce463c2500d6 0000-0003-0710-0947 Michael Gravenor Michael Gravenor true false 3676f695eeda169d0f8c618adf27c04b 0000-0001-6926-2947 Julian Halcox Julian Halcox true false 2018-03-01 MEDS Poster Contribution - ACC.18 Journal Article Journal of the American College of Cardiology 71 11 A74 Elsevier BV 0735-1097 1 3 2018 2018-03-01 10.1016/s0735-1097(18)30615-6 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-10-29T14:15:53.2857228 2018-03-01T00:00:00.0000000 Professional Services ISS - Uncategorised Daniel Harris 1 Arron Lacey 0000-0001-7983-8073 2 Ashley Akbari 0000-0003-0814-0801 3 Michael Gravenor 0000-0003-0710-0947 4 Julian Halcox 0000-0001-6926-2947 5 |
title |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
spellingShingle |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION Daniel Harris Arron Lacey Ashley Akbari Michael Gravenor Julian Halcox |
title_short |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
title_full |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
title_fullStr |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
title_full_unstemmed |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
title_sort |
EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION |
author_id_str_mv |
e60c9c73b645f0e8033ae26fa8e634b8 b69d245574e754d2637cc9e76379fe11 aa1b025ec0243f708bb5eb0a93d6fb52 70a544476ce62ba78502ce463c2500d6 3676f695eeda169d0f8c618adf27c04b |
author_id_fullname_str_mv |
e60c9c73b645f0e8033ae26fa8e634b8_***_Daniel Harris b69d245574e754d2637cc9e76379fe11_***_Arron Lacey aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley Akbari 70a544476ce62ba78502ce463c2500d6_***_Michael Gravenor 3676f695eeda169d0f8c618adf27c04b_***_Julian Halcox |
author |
Daniel Harris Arron Lacey Ashley Akbari Michael Gravenor Julian Halcox |
author2 |
Daniel Harris Arron Lacey Ashley Akbari Michael Gravenor Julian Halcox |
format |
Journal article |
container_title |
Journal of the American College of Cardiology |
container_volume |
71 |
container_issue |
11 |
container_start_page |
A74 |
publishDate |
2018 |
institution |
Swansea University |
issn |
0735-1097 |
doi_str_mv |
10.1016/s0735-1097(18)30615-6 |
publisher |
Elsevier BV |
college_str |
Professional Services |
hierarchytype |
|
hierarchy_top_id |
professionalservices |
hierarchy_top_title |
Professional Services |
hierarchy_parent_id |
professionalservices |
hierarchy_parent_title |
Professional Services |
department_str |
ISS - Uncategorised{{{_:::_}}}Professional Services{{{_:::_}}}ISS - Uncategorised |
document_store_str |
0 |
active_str |
0 |
description |
Poster Contribution - ACC.18 |
published_date |
2018-03-01T19:54:04Z |
_version_ |
1821345940011745280 |
score |
11.04748 |